PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshemochromatosis
MeSH D006432 - hemochromatosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019190:Iron overload
$
Success rate
D008664:Inborn errors metal metabolism
$
Success rate
D006432: 
Hemochromatosis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Dr Reddys LaboratoriesDeferoxamine Deferoxamine  2006-03-31   
Fresenius KabiDeferoxamine Deferoxamine  2009-09-15   
Gland PharmaDeferoxamine Deferoxamine  2017-09-29   
HospiraDeferoxamine Deferoxamine  2004-03-17   
NovartisDeferoxamine Desferal  1982-01-01   
West-Ward PharmaceuticalDeferoxamine Deferoxamine  2007-05-30   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
75%
3/4
Phase 3
40%
2/5
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use